ARCHIVES

In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit

This article is from The Cancer Letter archive.

Vol. 35 No. 46 | December 18, 2009

Download PDF Visit The Full Archive

Related Articles

Lenalidomide Safe As Single Therapy For Elderly Leukemia Patients, Study Finds

December 26, 2008

Michael Friedman To Head PhRMA’s Office Of Biomedical Preparedness.

November 2, 2001

NCI, Litton Open Talks On Frederick Contract

February 6, 1976

Children’s Oncology Group to Select New Chairman; Four Leaders to Step Aside

April 28, 2000

Longmire Reappointed To Cancer Panel

April 8, 1988

In Brief: Hellman Will Leave Harvard To Become Physician In Chief At Memorial. James Awards Announced

April 22, 1983